Literature DB >> 15635205

Conduction recovery after pulmonary vein isolation for atrial fibrillation.

Hiroo Noguchi1, Koichiro Kumagai, Tomoo Yasuda, Masahiro Ogawa, Hideaki Tojo, Keijiro Saku.   

Abstract

BACKGROUND: Although pulmonary vein (PV) isolation is useful for curing atrial fibrillation (AF), its recurrence rate is still high, so the aim of the present study was to investigate the cause of recurrence after PV isolation. METHODS AND
RESULTS: Eighty-five patients with paroxysmal AF underwent PV isolation and AF recurred in 48 patients after the first session. Thirty of these 48 patients who underwent a second session were evaluated. In 49 (71%) of 69 PVs ablated in 25 patients (83%), recovery of conduction was observed between the left atrium and PV. In 45 (92%) of 49 PVs, conduction recurrences were seen from the same segment or part of a segment that was ablated in the first session. However, in the other 4 PVs (8%), conduction recurrences occurred in a different segment that had not been ablated before. In the second session, the mean number of segments ablated in the PV ostium was significantly less than in the first session (2.3+/-5.0 vs 1.4+/-6.0, p<0.01). After the second session, 16 patients (53%) did not show recurrence of AF.
CONCLUSION: The major cause of recurrence of PV isolation was recovery of PV conduction from the same segment that had been ablated in the PV ostium. Therefore, an additional session may be necessary to increase the success rate.

Entities:  

Mesh:

Year:  2005        PMID: 15635205     DOI: 10.1253/circj.69.65

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  2 in total

Review 1.  Pilsicainide for atrial fibrillation.

Authors:  Koichiro Kumagai; Hideko Nakashima; Hideaki Tojo; Tomoo Yasuda; Hiroo Noguchi; Naomichi Matsumoto; Masahiro Ogawa; Keijiro Saku
Journal:  Drugs       Date:  2006       Impact factor: 9.546

2.  Pulmonary vein re-isolation for atrial fibrillation using duty-cycled phased radiofrequency ablation: safety and efficacy of a primary 2:1 bipolar/unipolar ablation mode.

Authors:  Marcus Wieczorek; Reinhard Hoeltgen; Shahram Tajtaraghi; Wolfgang Lawrenz; Michael Lukat
Journal:  J Interv Card Electrophysiol       Date:  2012-10-25       Impact factor: 1.900

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.